Bicycle Therapeutics (BCYC) Interest & Investment Income (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Interest & Investment Income of $4.9 million for Q1 2026, down 17.0% on a QoQ basis from $5.9 million in Q4 2025, and down 42.04% year-over-year from $8.4 million in Q1 2025.
Bicycle Therapeutics (BCYC) Interest & Investment Income (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $4.9 million for Q1 2026.
- Quarterly Interest & Investment Income fell 42.04% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.9 million (down 32.77% YoY) and the FY2025 annual result came in at $28.5 million, down 16.98% from the prior year.
- Interest & Investment Income was $4.9 million for Q1 2026 at Bicycle Therapeutics, down from $5.9 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $10.6 million in Q3 2024 and bottomed at $218000.0 in Q1 2022.
- A 5-year average of $5.1 million and a median of $5.6 million in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 8195.83% — and 2025, when it plunged 42.97%.
- Bicycle Therapeutics' Interest & Investment Income stood at $2.6 million in 2022, then surged by 137.82% to $6.3 million in 2023, then jumped by 64.17% to $10.3 million in 2024, then tumbled by 42.97% to $5.9 million in 2025, then dropped by 17.0% to $4.9 million in 2026.
- Business Quant data shows BCYC's Interest & Investment Income at $4.9 million in Q1 2026, $5.9 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Bicycle Therapeutics | 272.11 Mn | 272.11 Mn | - | 4.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.88 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 7.47 Mn |
| Mar 31, 2025 | 8.41 Mn |
| Dec 31, 2024 | 10.30 Mn |
| Sep 30, 2024 | 10.58 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 6.28 Mn |
| Sep 30, 2023 | 3.99 Mn |
| Jun 30, 2023 | 812,000.00 |
| Mar 31, 2023 | 2.93 Mn |
| Dec 31, 2022 | 2.64 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 908,000.00 |
| Mar 31, 2022 | 218,000.00 |
| Dec 31, 2021 | 59,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 23,000.00 |